Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AerSale (ASLE) Asset Writedowns and Impairment (2020 - 2025)

AerSale (ASLE) has 6 years of Asset Writedowns and Impairment data on record, last reported at $1.0 million in Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 15.31% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $966000.0, down 53.13%, while the annual FY2024 figure was $195000.0, 87.06% down from the prior year.
  • Asset Writedowns and Impairment reached $1.0 million in Q3 2025 per ASLE's latest filing, up from $750000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $7.1 million in Q4 2021 and bottomed at -$1.6 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $715789.5, with a median of $366000.0 recorded in 2022.
  • Peak YoY movement for Asset Writedowns and Impairment: skyrocketed 26528.57% in 2022, then tumbled 740.48% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $7.1 million in 2021, then crashed by 94.82% to $366000.0 in 2022, then plummeted by 31.15% to $252000.0 in 2023, then crashed by 740.48% to -$1.6 million in 2024, then skyrocketed by 162.02% to $1.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $1.0 million in Q3 2025, $750000.0 in Q2 2025, and $829000.0 in Q1 2025.